News
Public · Published
Pfizer Q2 Results: Stock up 5% after net profit jumps 66% on ₹132 crore one-time gain
Pfizer Ltd reported a 65.6% year-on-year rise in net profit to ₹313 crore for the second quarter, helped by a ₹132 crore one-time gain. Revenue from operations rose 13.2% to ₹727 crore, and shares ended up 3.63% at ₹3,770.00 on the BSE.
Published:
Updated:
What happened
Pfizer Ltd reported a 65.6% year-on-year rise in net profit to ₹313 crore for the second quarter, helped by a ₹132 crore one-time gain. Revenue from operations rose 13.2% to ₹727 crore, and shares ended up 3.63% at ₹3,770.00 on the BSE.
Confirmed
Global impact / market context
A large part of the profit jump came from a one-time gain, which means it is unlikely to repeat. Investors should separate that from the core business, where revenue grew 13.2% and EBITDA margin stayed flat at 36%, showing steady operations rather than a sudden profitability improvement.
Analyst inference
The stock's gain suggests investors responded to the headline profit growth, even though much of it came from the one-time gain. Flat EBITDA margin, which means the share of revenue left after operating costs, indicates pricing and cost pressures offset the benefit of higher sales.
Analyst inference
What to watch
- Watch whether Pfizer reports similar one-time gains in future quarters, since the ₹132 crore gain boosted net profit this quarter and may not repeat. Confirmed
- Watch whether revenue growth of 13.2% continues, because slower sales growth would reduce the cash available to fund operations and support profit. Proposed
- Watch whether EBITDA margin stays at 36%, since a flat margin means higher revenue is not translating into better profit per sale for the core business. Analyst inference
Evidence
- Original source link unavailable